Today's Core ThemeEquity markets enter October with a split personality. The major indices are within 2% of record highs, yet beneath the surface, a quiet rotation is underway. Investors are increasingly favoring cash-flow certainty over speculative growth, a dynamic underscored by Berkshire Hathaway's 11.3x P/E and 2.3% free cash flow yield. Meanwhile, the 10-year Treasury yield hovers near 4.2%, pressuring long-duration assets. This week's focus shifts to Friday's CPI print and the start of Q3 earnings season, where margin commentary will be critical. The Fed's higher-for-longer stance remains the backdrop, but with inflation cooling gradually, the debate is shifting from "how high" to "how long." In this environment, we see a market that rewards discipline and punishes excess. Stock Deep-Dive: Berkshire Hathaway (BRK-B)Berkshire Hathaway stands out as a bastion of value in an expensive market. At $502.65, BRK-B trades at just 11.3x earnings—a 50% discount to the S&P 500's forward multiple. Its 2.3% FCF yield may seem modest, but it's backed by a $150B+ cash pile and a portfolio of wholly-owned businesses generating consistent cash. Our health score of 8/10 reflects its fortress balance sheet and disciplined capital allocation. With no DCF fair value computed (due to the conglomerate's complexity), we rely on its historical valuation range: BRK-B has rarely traded below 1.3x book value, and current levels imply a modest premium. For long-term investors, this is a rare opportunity to own a diversified earnings machine at a reasonable price. Sector Radar & Key Levels**Technology:** Palantir (PLTR) trades at a staggering 149.8x P/E with a 0.5% FCF yield—a valuation that leaves no room for error. Broadcom (AVGO) at 44.1x P/E and 1.6% FCF yield is also stretched, though its AI-driven growth story provides some support. Watch for any pullback in these names as a signal of risk appetite. **Healthcare:** Eli Lilly (LLY) at 38.2x P/E and 0.6% FCF yield is priced for perfection. Its GLP-1 franchise is a cash cow, but competition and pricing pressure loom. A break below $1,100 could trigger momentum selling. **Energy:** ExxonMobil (XOM) at 21.1x P/E and 3.5% FCF yield offers a balanced risk-reward. Oil prices are range-bound, but XOM's integrated model provides downside protection. **Consumer Staples:** Walmart (WMT) at 37.6x P/E and 1.8% FCF yield is expensive for a low-growth retailer. Its defensive appeal is offset by valuation risk. **Key Levels:** S&P 500 support at 5,400; resistance at 5,600. 10-year yield above 4.3% would pressure growth stocks. Watch Friday's CPI (expect 3.1% y/y) and bank earnings kickoff. The Investor TakeawayIn a market where the average S&P 500 stock trades at 25x earnings, Berkshire's 11x multiple is an anomaly. We recommend rotating a portion of gains from high-flying tech into value names with strong cash flows. Palantir and Eli Lilly may continue to run, but the risk-reward is skewed negatively. For balanced portfolios, consider adding BRK-B and XOM on weakness. Stay cautious—October is known for volatility, and the Fed's next move is far from certain. Cash is not trash; it's optionality.
|